Scrolling UBI: Deloitte’s Fastest-Growing Mobile App
PulsePlay tops Deloitte’s North American fastest-growing software list, catalyzing investor interest as users earn mo...
Ways To Monetize Hobbies For Fast Income
Unlock ways to monetize hobbies for fast income. Turn your passions into cash and enjoy what you love while earning.
18,004 articles
At Some Point You’ve Got to Make Money: AI Skeptic Warns
A Goldman Sachs AI skeptic warns the market’s patience may be running thin as OpenAI and Anthropic gear up for mega-I...
Falls Back Near Iran: How Oil Shake Shapes Tech Stocks
Oil has eased from double-digit spikes as tensions with Iran ease, nudging markets toward calmer inflation expectatio...
SpaceX Looks Reshuffle Deck: A $60B Cursor Deal Transforms Investing
SpaceX is expanding beyond rockets with a bold $60B Cursor deal. This strategic shift could redefine how investors va...
Cathie Wood Sold Million: Is Alibaba a Sell Now, Really?
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
Finassets Raises Affiliate Revenue, Tops Crypto Payouts
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
Talkspace Stock Surged Today: Drivers Behind the Jump
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now
AI investing can feel crowded, but a pair of no-brainer artificial intelligence (ai) stocks stand out for durable gro...
Kettle Hill Bets Braze with 747,000-Share Initiation
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
Down 20%, Oracle No-Brainer AI Buy: A Practical Guide
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Advantage (ADV) 2025 Earnings Outlook and Strategies
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status